Speaker Profile
M.D., Executive Director Human Genetics, Genentech
Biography
Mark McCarthy is Executive Director of Human Genetics at Genentech, where he leads efforts within the company to use human genetics to advance the understanding of disease and further the development of novel therapeutic and preventative approaches. Prior to his move to the Bay Area in 2019, Mark was Robert Turner Professor of Diabetes Medicine at the University of Oxford. There, his research focused on genetic discovery in type 2 diabetes and related traits, and on using the causal insights derived from those analyses to drive biological inference and translational opportunities.
Session Abstract – PMWC 2026 Silicon Valley
Track Chair:
Ed Kim, City of Hope
PMWC Award Ceremony
• Mark Daly, Broad Institute / FinnGen
• Gordon Sanghera, Oxford Nanopore Technologies
The Data Factory: Integrating Millions of Genomes for Variant Interpretation
• Chair: Stephen Montgomery, Stanford University
• Carlos Bustamante, University of Oklahoma
• Mark Daly, Broad Institute
• Manuel Rivas, Stanford University
• Mark McCarthy, Genentech
• Nilah Ioannidis, UC Berkeley / UCSC
Beyond the Read: Long-Read Sequencing in Clinical Variant Pipelines
• Chair: Gordon Sanghera, Oxford Nanopore Technologies
• Hanlee Ji, Stanford University
• Barrett Bready, Nabsys
Keynote: Biobanks and the Road Ahead in Human Genetics
• Mark Daly, Broad Institute
AI & Evolution for Predicting Human Disease Genes
• Chair: Yuval Tabach, Hebrew University
• Nilah Ioannidis, UC Berkeley / UCSC
• Saša Jenko, European Commission
DNA to Drug, Label & Coverage
• Chair: Razelle Kurzrock, Medical College of Wisconsin
• Russ Altman, Stanford University
• Slavé Petrovski, AstraZeneca
• Wei Zhou, Broad Institute
25+ Years of the Human Genome: From Bench to Bedside to Beyond
• Chair: Ralph Snyderman, Duke University
• Craig Venter, J. Craig Venter Institute
• Brook Byers, KPCB
• Lee Hood, Phenome Health
PMWC Award Ceremony (Continued)
• Scott Gottlieb, Former FDA Commissioner
